Your browser doesn't support javascript.
loading
Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.
Wright, Katherine L; Adams, Jessica R; Liu, Jeff C; Loch, Amanda J; Wong, Ruth G; Jo, Christine E B; Beck, Lauren A; Santhanam, Divya R; Weiss, Laura; Mei, Xue; Lane, Timothy F; Koralov, Sergei B; Done, Susan J; Woodgett, James R; Zacksenhaus, Eldad; Hu, Pingzhao; Egan, Sean E.
Affiliation
  • Wright KL; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Adams JR; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Liu JC; Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Loch AJ; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Wong RG; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Jo CE; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Beck LA; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Santhanam DR; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Weiss L; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Mei X; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Lane TF; Department of Obstetrics and Gynecology and Department of Biological Chemistry, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California.
  • Koralov SB; Department of Pathology, New York University Medical Center, New York, New York.
  • Done SJ; Campbell Family Institute for Breast Cancer Research, University Health Network, Toronto, Ontario, Canada.
  • Woodgett JR; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Zacksenhaus E; Division of Cell and Molecular Biology, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Hu P; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Egan SE; Program in Developmental and Stem Cell Biology, The Peter Gilgan Center for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. segan@sickkids.ca.
Cancer Res ; 75(22): 4960-72, 2015 Nov 15.
Article in En | MEDLINE | ID: mdl-26400062

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Signal Transduction / Ras Proteins / Neoplasm Invasiveness Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Res Year: 2015 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Signal Transduction / Ras Proteins / Neoplasm Invasiveness Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Res Year: 2015 Type: Article Affiliation country: Canada